The results demonstrated that, in comparison to PBMCs, PKN2 expression was elevated in myeloid cells, M-MDSCs, and polymorphonuclear myeloid derived suppressor cells (PMN-MDSCs) of tumor tissues (Fig. 1F). This evidence concerns the gene PKN2 and neoplasm.